A heart perfusion imaging scan, or myocardial perfusion scan, is a test that tells doctors how well a person’s heart pumps blood. Doctors may use this test when diagnosing the cause of chest pain or ...
Using the Organ Care System (OCS) Heart platform to perfuse, optimize, and assess donor hearts has excellent outcomes, including 87% of extended criteria donor (ECD) hearts being successfully ...
The US Food and Drug Administration (FDA) has conditionally approved TransMedics Group’s investigational device exemption (IDE) to commence the next-generation OCS ENHANCE Heart study. Part A of the ...
Transmedics Group ((TMDX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for ...
Heart transplantation using the new strategy of donation after circulatory death (DCD) resulted in similar 6-month survival among recipients as the traditional method of using hearts donated after ...
ANDOVER, Mass., Aug. 4, 2025 /PRNewswire/ -- TransMedics Group, Inc. (TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback